期刊文献+

启东肝癌组织p53过表达的免疫组化检测 被引量:3

The p53 overexpression in Qidong liver cancer tissues analysed immunohistochemically
下载PDF
导出
摘要 目的 了解p5 3突变在启东地区的肝癌发生中所起的作用。方法 应用免疫组化 (IHC)的方法对 90例肝癌和 75例癌旁组织切片进行p5 3蛋白检测。结果 在 90例肝癌中 ,有 4 0例 (44 .4 % )在核中表达为强阳性 ,2 5例 (2 7.8% )在核中表达为弱阳性 ;在 75例癌旁中 ,没有细胞核强阳性表达 ,仅 1例 (1.3% )有核弱阳性表达 ;肝癌的p5 3核表达显著高于癌旁 (P =0 .0 0 0 )。另外 ,在肝癌中有 9例 (10 % )为细胞质p5 3表达阳性 ,在癌旁中有 17例 (2 2 .7% )为细胞质表达阳性 ,肝癌的胞质p5 3表达显著低于癌旁 (P =0 .0 2 6 )。结论 p5 3基因突变和p5 3的功能失活在启东的肝癌发展中有着重要意义。 Objective To explore the role of p53 mutation in the development of hepatocellular carcinoma (HCC) in Qidong area, which is one of the high incidence areas. Methods Immunohistochemical method (IHC) was used to detect p53 protein overexpression in 90 HCC tissues and 75 HCC-adjacent non-tumor liver tissues (as the control). Results In the 90 HCCs, 40(44.4%) were strongly positive and 25(27.8%) faintly positive for p53 in nucleus, while in the 75 control tissues, none was strongly positive and only 1( 1.3%) was faintly positive. The HCC's was significantly higher than the control's ( P =0.000). On the other hand, 9(10%) HCCs were positive for p53 in the cytoplasm, but 17(22.7%) control tissues were positive, the HCC's was significantly lower than the control's ( P =0.026). Conclusion p53 mutation and functionally inactivation played an important role in the development of HCC in Qidong area.
出处 《肿瘤》 CAS CSCD 北大核心 2002年第2期101-103,I002,共4页 Tumor
基金 国家九五攻关课题 :肝癌发生的分子病因学研究(专题号 :96-90 6-0 1-0 7)
关键词 P53 肝细胞肝癌 免疫组织化学 肝癌 上海 启东地区 基因突变 p53 Hepatocellular carcinoma Immunohistochemistry
  • 相关文献

参考文献14

  • 1[1]Greenblatt MS, Bennett WP, Hollstein M, et al. Mutations in the p53 rumor suppressor gene: clues to cancer etiology and molecular pathogenesis[J]. Cancer Res, 1994, 54:4855
  • 2[2]Lane DP, Benchirnol S. p53: oncogene or anti - onoogene[J].Genes Der, 1990, 4:1
  • 3[3]Levine AJ, Chang A, Dittmer D, et al. The p53 tumor suppressor gene [J]. Nature, 1991, 351:453
  • 4[4]Harris CC. p53 tumor suppressor gene: at the crossroads of molecular carcinogenesis, molecular epidemiology, and cancer risk assessment [J]. Environ Health Perspect, 1996, 104 (Suppl) 3:435
  • 5[5]Yang M, Zhou H, Kong RY, et al. Mutations at codon 249 of p53 gene in human heptocelluar carcinomas from Tongan, China [J]. Mutat Res, 1997, 381:25
  • 6[6]Soong R, Robbing PD, DIX B, et al. Concordance between p53protein overexpression and gene mutation in a large series of common human carcinomas [J]. Hum Pathol, 1996, 27(10): 1050
  • 7许昌泰,闫小君.p53抗癌基因和消化系肿瘤[J].世界华人消化杂志,1999,7(1):77-79. 被引量:21
  • 8[8]LiangTJ. p53 proteinsandaflatoxinBl: thegood, thebad, and the ugly [J]. Hepatology, 1995, 22(4): 1330
  • 9[9]Bosari S, Viale G, Roncalli M, et al. p53 gene mutations, p53protein accumulation and compartmentalization in colorectal adenocarcinoma [J]. Am J Pathol, 1995, 147:790
  • 10[10]Wertz IE, Deitch AD, Gumerlock PH, et al. Correlation of genetic and immunodetection of TP53 mutations in malignant and benign prostate tissues [J]. Hum Pathol, 1996, 27 (6): 573

二级参考文献4

共引文献20

同被引文献13

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部